gazette logo
   A Memorial University of Newfoundland Publication

mun logo
April 8, 2004
 Frontpage

 


Memorial researchers collaborate in gene discovery


Drs. Roger Green (L) and Ban Younghusband

Photo by HSIMS
Drs. Roger Green (L) and Ban Younghusband, researchers with Memorial’s Faculty of Medicine.

 

By Sharon Gray
Researchers at the Faculty of Medicine are major collaborators in the discovery of a novel gene relating to peripheral neuropathy. A study published in the April online edition of the American Journal of Human Genetics reports the discovery of the gene linked to hereditary sensory and autonomic neuropathy type II (HSAN II), a condition which causes loss of nerve sensation in the hands and feet.

Drs. William Pryse-Phillips, Banfield Younghusband and Roger Green from Memorial University and Dr. Bernard Brais of the Centre de Recherche du Centre Hospitalier de l’Université de Montréal identified several families with this rare condition in Eastern Canada. Researchers at Xenon Genetics Inc., a privately-owned drug discovery and development company based in Vancouver cloned and validated the gene – called HSN2 – underlying the disease in these families.

“The most important part of work is that we are finally in a position to help families with this disease,” said Dr. Ban Younghusband, chair of the Discipline of Genetics. “HSAN II has an early onset and can lead to severe disability. These findings will lead to our ability to offer DNA-based diagnostic testing and genetic counselling to those family members of who are at risk of developing the disease or of having children with the condition.”

Identification of the molecular basis of HSAN II is an important step in the diagnosis and future management of this and other peripheral neuropathies. This gene may play a role in the development or maintenance of peripheral sensory neurons or their supporting cells. It is also possible that a drug based on the action of HSN2 could be used to prevent or treat features of peripheral neuropathy, including that resulting from diabetes.

Drs. William Pryse-Phillips
Drs. William Pryse-Phillips

Neurologist Dr. William Pryse-Phillips began working with patients with hereditary neuropathy in 1972, when he first came to Newfoundland. Using information gathered by neurologist Dr. Max House, he began to gather further information on families, mainly in the Notre Dame Bay area, with the disease.

Passing information over to colleagues Drs. Younghusband and Green and well as Dr. Sharon Buehler, now honorary research professor, Dr. Pryse-Phillips’ role was to make a final diagnosis of the type of hereditary neuropathy the patient had, as well as to treat the patient. Treatment involves counselling on the need to constantly inspect and protect feet, treating pain, and promptly treating complications such as cuts.

Dr. Pryse-Phillips, recently retired, said he was delighted with the identification of the HSAN II gene and credited the work of all those involved for its “obsessive precision.” He said his ability to be clinically certain of the type of hereditary neuropathy each patient had was instrumental in Xenon’s skilful detection of the gene.

In November 2000, Xenon and Memorial University signed an agreement to collaborate on three genetic diseases that are prevalent in Newfoundland and Labrador. The agreement with Memorial was negotiated through the university’s commercialization organization, the Genesis Group. “This agreement, which involved Xenon collaborating with university researchers in St. John’s and Montreal, was a blueprint for how things should be done in Canada” said David King, president of the Genesis Group. “This collaboration was possible because Memorial had access to the unique founder population in this province and because the Faculty of Medicine had the foresight in 1999 to set up a dedicated Discipline of Genetics. But this is just the beginning, genetic research carried out in Canada and at Memorial will bring great benefit to society over the next decade.”


 


     Top Stories

Dr.  David Natcher
Dr. Richard Rivkin
Jenine Browne
Dr. Robert Greenwood

Next issue: April 29, 2004

Questions? Comments?
E-mail our editor.